Ledger.Open graph →
SEC Form D · filed April 20, 2021

Goldilocks Therapeutics, Inc

Offering
$1.2M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEDFORD, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Scott Minick · La Jolla, CADirectorKrishna Polu · Philadelphia, PADirectorArthur Klausner · Bedford, NYExec · DirectorScott Minick · Vernon Hills, ILDirectorKrishna Polu · Philadelphia, PADirectorArthur Klausner · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗